id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id FDA-1995-S-0036-0135,FDA,FDA-1995-S-0036,"Resuscitation Outcomes Consortium (ROC) re IND 110280, British Columbia, Canada Public Disclosure Material Report 63 - Report",Other,Report,2012-12-28T05:00:00Z,2012,12,2012-12-28T05:00:00Z,,2014-11-28T19:44:04Z,,0,0,090000648118f830 FDA-1995-S-0036-0136,FDA,FDA-1995-S-0036,"University of Texas Health Science Center at Houston re IND 14929, University of Alabama Public Disclosure Material Report 64 - Report",Other,Report,2012-12-28T05:00:00Z,2012,12,2012-12-28T05:00:00Z,,2014-11-28T19:44:18Z,,0,0,090000648118f832 FDA-1995-S-0036-0137,FDA,FDA-1995-S-0036,"Rampart Neurological Emergencies Treatment Trials Neuro Emergencies Research, Community Consultion and Public Disclosure IND 102254 Report 65 - Report",Other,Report,2012-12-28T05:00:00Z,2012,12,2012-12-28T05:00:00Z,,2014-11-28T19:44:31Z,,0,0,090000648119e1fd FDA-1995-S-0036-0134,FDA,FDA-1995-S-0036,"Resuscitation Outcomes Consortium (ROC) re IND 110280, Alabama Public Disclosure Material Report 62 - Report",Other,Report,2012-12-17T05:00:00Z,2012,12,2012-12-17T05:00:00Z,,2014-11-28T19:43:50Z,,0,0,090000648117af5b FDA-1995-S-0036-0130,FDA,FDA-1995-S-0036,"University of Texas Health Science Center at Houston, Sites University of Arizona, Toronto Sunnybrook Health Science, and Oregon Health & Science University, Public Disclosure Material, IND 14929 Report 56 - Report",Other,Report,2012-11-30T05:00:00Z,2012,11,2012-11-30T05:00:00Z,,2014-11-28T19:42:46Z,,0,0,0900006481136a1b FDA-1995-S-0036-0133,FDA,FDA-1995-S-0036,"Resuscitation Outcomes Consortium (ROC) re IND 110280, Ottawa Public Disclosure Material Report 61 - Report",Other,Report,2012-11-30T05:00:00Z,2012,11,2012-11-30T05:00:00Z,,2014-11-28T19:43:35Z,,0,0,090000648116f518 FDA-1995-S-0036-0131,FDA,FDA-1995-S-0036,"University of Texas Health Science Center at Houston, Site University of Washington, Public Disclosure Material Report 59 - Report",Other,Report,2012-11-30T05:00:00Z,2012,11,2012-11-30T05:00:00Z,,2014-11-28T19:43:01Z,,0,0,0900006481167d02 FDA-1995-S-0036-0132,FDA,FDA-1995-S-0036,"Penn Medicine Hospital of the University of Pennsylvania, IND 110314 Report 60 - Report",Other,Report,2012-11-30T05:00:00Z,2012,11,2012-11-30T05:00:00Z,,2014-11-28T19:43:15Z,,0,0,090000648116f517 FDA-1995-S-0036-0128,FDA,FDA-1995-S-0036,Resuscitation Outcomes Consortium (ROC) Pittsburgh Public Disclosure Materials Report 57 - Report,Other,Report,2012-11-14T05:00:00Z,2012,11,2012-11-14T05:00:00Z,,2014-11-28T19:42:19Z,,0,0,0900006481159612 FDA-1995-S-0036-0129,FDA,FDA-1995-S-0036,"University of Texas Health Science Center at Houston, Site University of Southern California Los Angeles, Public Disclosure Material Report 58 - Report",Other,Report,2012-11-14T05:00:00Z,2012,11,2012-11-14T05:00:00Z,,2014-11-28T19:42:32Z,,0,0,0900006481159613 FDA-1995-S-0036-0127,FDA,FDA-1995-S-0036,Eunice Kennedy Shriver National Institute of Child Health and Human Development Public Disclosure Materials re IND 79010 Lorazepam Report 55 - Report,Other,Report,2012-11-01T04:00:00Z,2012,11,2012-11-01T04:00:00Z,,2014-11-28T19:42:00Z,,0,0,0900006481131644 FDA-1995-S-0036-0126,FDA,FDA-1995-S-0036,Resuscitation Outcomes Consortium (ROC) British Columbia Public Disclosure Materials re IND 110699 Report 54 - Report,Other,Report,2012-09-20T04:00:00Z,2012,9,2012-09-20T04:00:00Z,,2014-11-28T19:41:42Z,,0,0,0900006481113f5e FDA-1995-S-0036-0125,FDA,FDA-1995-S-0036,"University of Texas Health Science Center at Houston, University of Cincinnati Academic Health Center, University of California, San Fancisco General Hospital, and the University of Tennessee Health Science Center Public Disclosure Materials re IND 14929 Report 53 - Report",Other,Report,2012-09-17T04:00:00Z,2012,9,2012-09-17T04:00:00Z,,2014-11-28T19:41:27Z,,0,0,09000064810f87aa FDA-1995-S-0036-0124,FDA,FDA-1995-S-0036,"Resuscitation Outcomes Consortium (ROC) re IND 110699, Alabama Public Disclosure Material Report 52 - Report",Other,Report,2012-08-10T04:00:00Z,2012,8,2012-08-10T04:00:00Z,,2014-11-28T19:41:15Z,,0,0,09000064810c9d2e FDA-1995-S-0036-0123,FDA,FDA-1995-S-0036,"Resuscitation Outcomes Consortium (ROC) re IND 110699, Portland Public Disclosure Material Report 51 - Report",Other,Report,2012-07-23T04:00:00Z,2012,7,2012-07-23T04:00:00Z,,2014-11-28T19:41:00Z,,0,0,09000064810a0006 FDA-1995-S-0036-0122,FDA,FDA-1995-S-0036,"Resuscitation Outcomes Consortium (ROC) re IND 110699, Milwaukee Public Disclosure Material Report 50 - Report",Other,Report,2012-07-12T04:00:00Z,2012,7,2012-07-12T04:00:00Z,,2014-11-28T19:40:47Z,,0,0,090000648108a994 FDA-1995-S-0036-0121,FDA,FDA-1995-S-0036,"Attachment - Community Consultantion for ResQPRO Clinical Trial (Advanced Circulatory Systems, Inc., to the Division of Dockets Management re: IDE G080169, ResQpro Clinical Trial, Community Consultation Plan - Report) re FDA-1995-S-0036-0112",Supporting & Related Material,Report,2012-07-12T04:00:00Z,2012,7,,,2014-11-28T19:38:30Z,,0,0,0900006480e373e6 FDA-1995-S-0036-0120,FDA,FDA-1995-S-0036,"Resuscitation Outcomes Consortium (ROC) re IND 110280, Toronto Public Disclosure Material Report 49 - Report",Other,Report,2012-06-11T04:00:00Z,2012,6,2012-06-11T04:00:00Z,,2014-11-28T19:40:34Z,,0,0,09000064810420f5 FDA-1995-S-0036-0119,FDA,FDA-1995-S-0036,"Resuscitation Outcomes Consortium (ROC) re IND 110280, San Diego Public Disclosure Material Report 48 - Report",Other,Report,2012-06-01T04:00:00Z,2012,6,2012-06-01T04:00:00Z,,2014-11-28T19:40:21Z,,0,0,0900006481025646 FDA-1995-S-0036-0118,FDA,FDA-1995-S-0036,"ProTECT Emergency Neurosciences Department of Emergency Medicine (Emory University Scool of Medicine) re IND 104 188, Institutional Review Board Public Disclosure Material Report 47 - Report",Other,Report,2012-04-26T04:00:00Z,2012,4,2012-04-26T04:00:00Z,,2014-11-28T19:40:05Z,,0,0,0900006480ff7ad9 FDA-1995-S-0036-0117,FDA,FDA-1995-S-0036,"Resuscitation Outcomes Consortium (ROC) re IND 110280, Final Community Consultation Plan Public Disclosure Material Report 46 - Report",Other,Report,2012-04-24T04:00:00Z,2012,4,2012-04-24T04:00:00Z,,2014-11-28T19:39:51Z,,0,0,0900006480ff17ed FDA-1995-S-0036-0116,FDA,FDA-1995-S-0036,Penn Medicine Hospital of the University of Pennsylvania Community Consultation and Public Disclosure AVERT Shock Trial IRB Protocol 811293 Report 45 - Report,Other,Report,2012-04-04T04:00:00Z,2012,4,2012-04-04T04:00:00Z,,2014-11-28T19:39:37Z,,0,0,0900006480fe6925 FDA-1995-S-0036-0113,FDA,FDA-1995-S-0036,"Resuscitation Outcomes Consortium (ROC) re IND 110699, Community Consultation Plan Public Disclosure Material Report 42 - Report",Other,Report,2012-04-02T04:00:00Z,2012,4,2012-04-02T04:00:00Z,,2014-11-28T19:38:58Z,,0,0,0900006480fdb2e5 FDA-1995-S-0036-0115,FDA,FDA-1995-S-0036,"Neuren Pharmaceuticals, Ltd., re IND 111724, Exception FromxInformed Consent Requirements for Emergency Research Public Disclosure Information Report 44 - Report",Other,Report,2012-04-02T04:00:00Z,2012,4,2012-04-02T04:00:00Z,,2014-11-28T19:39:25Z,,0,0,0900006480fdb2e6 FDA-1995-S-0036-0114,FDA,FDA-1995-S-0036,"Resuscitation Outcomes Consortium (ROC) re IND 110280, Community Consultation Plan Public Disclosure Material Report 43 - Report",Other,Report,2012-04-02T04:00:00Z,2012,4,2012-04-02T04:00:00Z,,2014-11-28T19:39:12Z,,0,0,0900006480fdb2e3